home · filing · 0001493152-26-021877
8-K
filed May 8, 2026, 7:59 PM ET
CIK 0001657045
leadership
confidence high
sentiment neutral
materiality 0.25
Next-ChemX appoints two new directors and changes corporate address
NEXT-ChemX Corporation.
Thomas P. Killoran appointed to Board; background in real estate development and civil litigation.
Ian Carey appointed to Board; decades of experience in commercial/residential construction.
Both appointments effective January 12, 2026; no family relationships or reportable transactions.
New corporate address: 9101 West Alta Drive, Suite 202, Las Vegas, NV 89145.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Ian Carey
Director
NEXT-ChemX Corporation.
Effective 2026-01-12
Filed May 8, 2026, 7:59 PM ET
On January 12, 2026, Next-ChemX Corporation (the "Company") appointed two people to the Company’s Board of Directors ("Board").
Appointed
Thomas P. Killoran
Director
NEXT-ChemX Corporation.
Effective 2026-01-12
Filed May 8, 2026, 7:59 PM ET
On January 12, 2026, Next-ChemX Corporation (the "Company") appointed two people to the Company’s Board of Directors ("Board").
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ian Carey was appointed as Director at NEXT-ChemX Corporation..
Action appointed
Role Director
Exact text from the filing
On January 12, 2026, Next-ChemX Corporation (the "Company") appointed two people to the Company’s Board of Directors ("Board").
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas P. Killoran was appointed as Director at NEXT-ChemX Corporation..
Action appointed
Role Director
Exact text from the filing
On January 12, 2026, Next-ChemX Corporation (the "Company") appointed two people to the Company’s Board of Directors ("Board").
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-26-021877
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.